ATC Group: B05AA01 Albumin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B05AA01 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B05 Blood substitutes and perfusion solutions
3 B05A Blood and related products
4 B05AA Blood substitutes and plasma protein fractions
5 B05AA01 Albumin

Active ingredients in B05AA01

Active Ingredient Description
Albumin

Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents about 10% of the protein synthesis activity of the liver. The most important physiological functions of albumin results from its contribution to oncotic pressure of the blood and transport function. Albumin stabilises circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins.

Related product monographs

Title Information Source Document Type  
ALBUMAN Solution for infusion Marketing Authorisation Holder MPI, EU: SmPC
ALBUNORM Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ALBUREX 20, 200g/l Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ALBUREX 5, 50 g/l Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ALBURX Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
ALBUTEIN Solution for infusion FDA, National Drug Code (US) MPI, US: SPL/PLR
OCTALBIN Solution for infusion Health Products and Food Branch (CA) MPI, CA: SPM

Medicines in this ATC group

United States (US)

Canada (CA)

Ecuador (EC)

Estonia (EE)

Finland (FI)

Israel (IL)

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.